Medical Aspects of the Treatment of LUTS/BPH: Combination Therapies
Author:
Publisher
Elsevier
Reference74 articles.
1. Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia;Napalkov;Urology,1995
2. Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management;Emberton;Int J Clin Pract,2008
3. Medical treatment of benign prostatic hyperplasia;Lepor;Rev Urol,2011
4. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia;Lepor;N Engl J Med,1996
5. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group;Debruyne;Eur Urol,1998
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. α1-adrenoceptor antagonists and 5α-reductase inhibitors for urinary tract symptoms in benign prostatic hyperplasia;Journal of Paramedic Practice;2024-02-02
2. A novel eco-friendly HPLC method with dual detection modes for versatile quantification of dutasteride and silodosin in pharmaceutical formulation, dissolution testing and spiked human plasma;Microchemical Journal;2024-02
3. State-of-the-art mathematically induced filtration approaches for smart spectrophotometric assessment of silodosin and solifenacin mixture in their new challenging formulation: Multi-tool greenness and whiteness evaluation;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-02
4. Double-J stent-related lower urinary tract symptoms: a prospective randomized trial of mirabegron, solifenacin, tamsulosin, and tadalafil and their combinations;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2023-11
5. Smart spectrophotometric assessment of tamsulosin hydrochloride and tadalafil in their new pharmaceutical formulation for treatment of benign prostatic hyperplasia and erectile dysfunction;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2020-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3